Faceprint Global Solutions

FacePrint is a digital health company developing an AI-powered screening tool for the early detection of Parkinson's disease. The technology utilizes computer vision and machine learning to analyze subtle changes in facial expressions and spontaneous muscle movements, which can appear years before traditional motor symptoms. By providing a non-invasive, accessible diagnostic aid, FacePrint aims to enable earlier intervention and improve clinical trial recruitment for neurodegenerative disorders. The company's platform was developed in collaboration with the Michael J. Fox Foundation and academic researchers to identify digital biomarkers of neurological health.